Top News and Analysis for R&D and Executive Leaders

 

Week of 7.2.08

tbar.gif


Best Practices
Click here to
submit entries

Neil W Gibson of OSI Pharmaceuticals

Jeffrey Settleman Harvard Medical School and MGH Cancer Center

David Bailey of Chemoventures

N Claude Cohen of Synergix

-View All Webcasts

 

 

 
     

 

 

Business

The Long Wait for Pfizer

April 17, 2008—Pfizer shares fall as investors wait for some piece of hope to reverse a long, slow decline. Pfizer shares dropped 4% this morning as it missed Wall Street earnings-per-share estimates by 8% and sales of cholesterol-reducer Lipitor, the world's top-selling drug fell 7% from a year ago. Pfizer said it was sticking by its financial guidance for the year. Forbes

 

Genstruct: Patience, Persistence, and Payoff 
By John Russell

Finding the right business model for systems biology (SB) technology providers has been challenging — that’s hardly a new theme in biotech.

Click here


 


PharmaWeek
is subject to the terms and conditions of use
Please read the important legal notices and disclaimers contained in these terms and
conditions of use.


Copyright 2005  Cambridge Healthtech Institute  |  250 First Avenue  |   Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425